Condition

Recurrent Endometrial Carcinoma clinical trials and research

• 10Clinical trials
• 3Countries

Newest Recurrent Endometrial Carcinoma clinical trials

All recruiting trials (10)

• Adding bevacizumab to carboplatin, paclitaxel and pembrolizumab for pMMR, TP53‑mutated advanced or recurrent endometrial cancer

  This trial tests whether adding bevacizumab to carboplatin and paclitaxel with pembrolizumab helps people with pMMR, TP53‑mutated advanced or recurrent endometrial cancer live longer without the disease getting worse.

  Recruiting at 308 sites Phase 3 National Cancer Institute (NCI) · Birmingham, Alabama and 308 other locations · NCT07198074

• Combining Carboplatin, Paclitaxel, and Pembrolizumab for Advanced Endometrial Cancer

  This study is testing a new combination of drugs for people with advanced endometrial cancer to see if it helps them live longer without their cancer getting worse.

  Recruiting at 6 sites Phase 2 Yonsei University · Kyeonggi-do and 5 other locations · NCT06502743

• Predicting how tumors respond to immune therapies using a live diagnostic platform

  This study is testing a new way to predict how well immune therapies will work for patients with different types of solid tumors, including early-stage and metastatic cancers.

  Recruiting at 3 sites Mayo Clinic · Phoenix, Arizona and 2 other locations · NCT06349642

• Combining nab-Sirolimus and Letrozole for advanced endometrial cancer

  This study is testing if a new combination of two medications, nab-sirolimus and letrozole, can help people with advanced endometrial cancer feel better and manage their disease.

  Recruiting at 9 sites Phase 2 Aadi Bioscience, Inc. · Little Rock, Arkansas and 8 other locations · NCT05997017

• Testing drug combinations for recurrent ovarian and endometrial cancer

  This study is testing a combination of two drugs to see if they can safely help people with recurrent ovarian and endometrial cancer by blocking tumor growth.

  Recruiting at 13 sites Phase 1 National Cancer Institute (NCI) · Augusta, Georgia and 13 other locations · NCT05950464

• Combining Lenvatinib, Pembrolizumab, and Radiation Therapy for Advanced Endometrial Cancer

  This study is testing a new treatment that combines two medications and radiation therapy to see if it can help people with advanced endometrial cancer feel better and improve their outcomes.

  Recruiting Phase 1 University of Miami · Miami, Florida · NCT05603910

• Targeted therapy for advanced solid tumors based on genetic testing

  This study is testing whether matching patients with advanced solid tumors to specific treatments based on their genetic makeup can improve their outcomes when standard options have failed.

  Recruiting at 437 sites Phase 2 National Cancer Institute (NCI) · Birmingham, Alabama and 483 other locations · NCT05564377

• Testing nivolumab with or without ipilimumab for recurrent endometrial cancer

  This study is testing if adding ipilimumab to nivolumab can help people with recurrent endometrial cancer live longer and feel better compared to just using nivolumab alone.

  Recruiting at 122 sites Phase 2 National Cancer Institute (NCI) · Birmingham, Alabama and 137 other locations · NCT05112601

• Using abemaciclib to treat recurrent ovarian or endometrial cancer

  This study is testing if the drug abemaciclib can help people with recurrent ovarian or endometrial cancer stay cancer-free for at least 16 weeks.

  Recruiting Phase 2 Jonsson Comprehensive Cancer Center · Los Angeles, California · NCT04469764

• Combining talazoparib with radiation therapy for recurrent gynecologic cancers

  This study is testing if combining a drug called talazoparib with radiation therapy can safely help people with recurrent gynecologic cancers feel better.

  Recruiting at 2 sites Phase 1 M.D. Anderson Cancer Center · Baltimore, Maryland and 1 other locations · NCT03968406

Related topics

Quick answers

How many Recurrent Endometrial Carcinoma clinical trials are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (9 trials), South Korea (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →